Effects of N-acetylcysteine on substance use in bipolar disorder: A randomised placebo-controlled clinical trial

Michelle Bernardo, Seetal Dodd, Clarissa S. Gama, David L. Copolov, Olivia Dean, Kristy Kohlmann, Susan Jeavons, Ian Schapkaitz, Murray Anderson-Hunt, Ashley I. Bush, Michael Berk

    Research output: Contribution to journalArticleResearchpeer-review

    8 Citations (Scopus)

    Abstract

    Objective: To evaluate the effect of N-acetylcysteine (NAC) on substance use in a double-blind, placebo-controlled trial of NAC in bipolar disorder. It is hypothesised that NAC will be superior to placebo for reducing scores on the Clinical Global Impressions scale for Substance Use (CGI-SU). Methods: Participants were randomised to a 6-months of treatment with 2 g/day NAC (n = 38) or placebo (n = 37). Substance use was assessed at baseline using a Habits instrument. Change in substance use was assessed at regular study visits using the CGI-SU. Results: Among the 75 participants 78.7% drank alcohol (any frequency), 45.3% smoked tobacco and 92% consumed caffeine. Other substances were used by fewer than six participants. Caffeine use was significantly lower for NAC-treated participants compared to placebo at week 2 of treatment but not at other study visits. Conclusions: NAC appeared to have little effect on the participants who were using substances. A larger study on a substance-using population will be necessary to determine if NAC may be a useful treatment for substance use.

    Original languageEnglish
    Pages (from-to)285-291
    Number of pages7
    JournalActa Neuropsychiatrica
    Volume21
    Issue number6
    DOIs
    Publication statusPublished - 1 Jan 2009

    Keywords

    • Alcohol
    • Bipolar disorder
    • Caffeine
    • Clinical trial
    • N-acetyl cysteine
    • Smoking
    • Substance use

    Cite this

    Bernardo, M., Dodd, S., Gama, C. S., Copolov, D. L., Dean, O., Kohlmann, K., Jeavons, S., Schapkaitz, I., Anderson-Hunt, M., Bush, A. I., & Berk, M. (2009). Effects of N-acetylcysteine on substance use in bipolar disorder: A randomised placebo-controlled clinical trial. Acta Neuropsychiatrica, 21(6), 285-291. https://doi.org/10.1111/j.1601-5215.2009.00397.x